TREVENTIS™ Corporation is an early stage biotechnology company focused on diseases associated with protein misfolding such as Alzheimer’s, Parkinson’s and Huntington’s.  Currently, the Company has two major areas of discovery and development including: (1) the development of drugs that halt Alzheimer’s disease (and other dementias) progression with the promise of stabilizing or improving cognition and (2) the development of companion diagnostics for detection of AD to allow for early drug intervention to minimize neuronal loss.